Oncogenic K-Ras Activates p38 to Maintain Colorectal Cancer Cell Proliferation during MEK Inhibition

Background: Colon carcinomas frequently contain activating mutations in the K-ras proto-oncogene. K-ras itself is a poor drug target and drug development efforts have mostly focused on components of the classical Ras-activated MEK/ERK pathway. Here we have studied whether endogenous oncogenic K-ras...

Full description

Saved in:
Bibliographic Details
Main Authors: Winan J. van Houdt, Menno T. de Bruijn, Benjamin L. Emmink, Danielle Raats, Frederik J. H. Hoogwater, Inne H. M. Borel Rinkes, Onno Kranenburg
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Cellular Oncology
Online Access:http://dx.doi.org/10.3233/CLO-2010-0521
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850106798082621440
author Winan J. van Houdt
Menno T. de Bruijn
Benjamin L. Emmink
Danielle Raats
Frederik J. H. Hoogwater
Inne H. M. Borel Rinkes
Onno Kranenburg
author_facet Winan J. van Houdt
Menno T. de Bruijn
Benjamin L. Emmink
Danielle Raats
Frederik J. H. Hoogwater
Inne H. M. Borel Rinkes
Onno Kranenburg
author_sort Winan J. van Houdt
collection DOAJ
description Background: Colon carcinomas frequently contain activating mutations in the K-ras proto-oncogene. K-ras itself is a poor drug target and drug development efforts have mostly focused on components of the classical Ras-activated MEK/ERK pathway. Here we have studied whether endogenous oncogenic K-ras affects the dependency of colorectal tumor cells on MEK/ERK signaling.
format Article
id doaj-art-4daa0ec8b6934c30a46edea6cf1b18a1
institution OA Journals
issn 1570-5870
1875-8606
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Cellular Oncology
spelling doaj-art-4daa0ec8b6934c30a46edea6cf1b18a12025-08-20T02:38:45ZengWileyCellular Oncology1570-58701875-86062010-01-0132424525710.3233/CLO-2010-0521Oncogenic K-Ras Activates p38 to Maintain Colorectal Cancer Cell Proliferation during MEK InhibitionWinan J. van Houdt0Menno T. de Bruijn1Benjamin L. Emmink2Danielle Raats3Frederik J. H. Hoogwater4Inne H. M. Borel Rinkes5Onno Kranenburg6Department of Surgery, University Medical Center Utrecht, Heidelberglaan, Utrecht, The NetherlandsDepartment of Surgery, University Medical Center Utrecht, Heidelberglaan, Utrecht, The NetherlandsDepartment of Surgery, University Medical Center Utrecht, Heidelberglaan, Utrecht, The NetherlandsDepartment of Surgery, University Medical Center Utrecht, Heidelberglaan, Utrecht, The NetherlandsDepartment of Surgery, University Medical Center Utrecht, Heidelberglaan, Utrecht, The NetherlandsDepartment of Surgery, University Medical Center Utrecht, Heidelberglaan, Utrecht, The NetherlandsDepartment of Surgery, University Medical Center Utrecht, Heidelberglaan, Utrecht, The NetherlandsBackground: Colon carcinomas frequently contain activating mutations in the K-ras proto-oncogene. K-ras itself is a poor drug target and drug development efforts have mostly focused on components of the classical Ras-activated MEK/ERK pathway. Here we have studied whether endogenous oncogenic K-ras affects the dependency of colorectal tumor cells on MEK/ERK signaling.http://dx.doi.org/10.3233/CLO-2010-0521
spellingShingle Winan J. van Houdt
Menno T. de Bruijn
Benjamin L. Emmink
Danielle Raats
Frederik J. H. Hoogwater
Inne H. M. Borel Rinkes
Onno Kranenburg
Oncogenic K-Ras Activates p38 to Maintain Colorectal Cancer Cell Proliferation during MEK Inhibition
Cellular Oncology
title Oncogenic K-Ras Activates p38 to Maintain Colorectal Cancer Cell Proliferation during MEK Inhibition
title_full Oncogenic K-Ras Activates p38 to Maintain Colorectal Cancer Cell Proliferation during MEK Inhibition
title_fullStr Oncogenic K-Ras Activates p38 to Maintain Colorectal Cancer Cell Proliferation during MEK Inhibition
title_full_unstemmed Oncogenic K-Ras Activates p38 to Maintain Colorectal Cancer Cell Proliferation during MEK Inhibition
title_short Oncogenic K-Ras Activates p38 to Maintain Colorectal Cancer Cell Proliferation during MEK Inhibition
title_sort oncogenic k ras activates p38 to maintain colorectal cancer cell proliferation during mek inhibition
url http://dx.doi.org/10.3233/CLO-2010-0521
work_keys_str_mv AT winanjvanhoudt oncogenickrasactivatesp38tomaintaincolorectalcancercellproliferationduringmekinhibition
AT mennotdebruijn oncogenickrasactivatesp38tomaintaincolorectalcancercellproliferationduringmekinhibition
AT benjaminlemmink oncogenickrasactivatesp38tomaintaincolorectalcancercellproliferationduringmekinhibition
AT danielleraats oncogenickrasactivatesp38tomaintaincolorectalcancercellproliferationduringmekinhibition
AT frederikjhhoogwater oncogenickrasactivatesp38tomaintaincolorectalcancercellproliferationduringmekinhibition
AT innehmborelrinkes oncogenickrasactivatesp38tomaintaincolorectalcancercellproliferationduringmekinhibition
AT onnokranenburg oncogenickrasactivatesp38tomaintaincolorectalcancercellproliferationduringmekinhibition